Lindsay Lipke, M.D.
Pediatric Dermatology Physician in Little Rock, Arkansas. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 222 in Pediatric Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Lindsay Lipke, M.D. reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 1,012 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 1K
- Part D claims, 2023
- 82%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Lindsay Lipke, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lindsay Lipke, M.D. sits
This provider among pediatric dermatology physician peers
Across the 65 pediatric dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lindsay Lipke, M.D. writes more Part D claims than 80% of them and scores higher on MIPS quality than 85% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pediatric dermatology physician peer from a representative sample of 60; the gold marker is Lindsay Lipke, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Lindsay Lipke, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lindsay Lipke, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arkansas
How Pediatric Dermatology Physician compares to other specialties among Arkansas providers
Pediatric Dermatology Physician ranks #356 among Arkansas's specialties (0% of in-state providers)
Each bar is a specialty's share of the Arkansas provider total, by primary NUCC taxonomy. The highlighted bar is Pediatric Dermatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Lindsay Lipke, M.D.'s 2023 MIPS final score plotted against the Pediatric Dermatology Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Dermatology Physician) - 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Pediatric Dermatology Physician US NPIs
100/100 MIPS final score - 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pediatric Dermatology Physician. Quality dim: 100.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Lindsay Lipke, M.D. appears in the CMS NPPES registry as a Pediatric Dermatology Physician provider holding M.D. credentials at 9601 BAPTIST HEALTH DR, Little Rock, AR, 72205, with a listed phone of (501) 227-8422. NPI 1225052731 was issued on 07/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Lipke most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,012 prescription claims written by this provider, covering 382 Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Pediatric Dermatology Physician is a narrow specialty nationwide, with 222 enrolled providers across 39 states and an average of 497 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225052731 |
|---|---|
| Specialty | Pediatric Dermatology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 07/27/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Lindsay Lipke, M.D.'s current license status, disciplinary history, and board certifications with the Arkansas State Medical Board in Arkansas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Lindsay Lipke, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lindsay Lipke, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$599
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
18% brand-name claims vs 82% generic, on 1,012 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,134
- Total Day Supply
- 29,618
- Brand vs Generic
- 18% brand / 82% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $38K
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 70.4 years
- Avg HCC Risk Score
- 1.13
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 59, 65-74: 188, 75-84: 119, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Lindsay Lipke, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ketoconazole
Ketoconazole
118 claims
- Mupirocin
Mupirocin
110 claims
- Triamcinolone Acet…
Triamcinolone Acetonide
95 claims
- Betamethasone Dipr…
Betamethasone Dipropionate
81 claims
- Clobetasol Propion…
Clobetasol Propionate
65 claims
- Imiquimod 46
Imiquimod
46 claims
- Desonide 42
Desonide
42 claims
- Mometasone Furoate 30
Mometasone Furoate
30 claims
| Drug | Claims |
|---|---|
| Ketoconazole | 118 |
| Mupirocin | 110 |
| Triamcinolone Acetonide | 95 |
| Betamethasone Dipropionate | 81 |
| Clobetasol Propionate | 65 |
| Imiquimod | 46 |
| Desonide | 42 |
| Mometasone Furoate | 30 |
| Taltz Autoinjector Ixekizumab | 30 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Dermatology Physician Overview
How Lindsay Lipke, M.D. fits within the Pediatric Dermatology Physician landscape nationally.
Lindsay Lipke, M.D.'s 1,012 claims are above the specialty average of 497.
Nearby Pediatric Dermatology Physician Providers in Arkansas
Other clinicians with the same primary specialty enrolled in Arkansas, drawn from the same CMS NPPES roster as Lipke.
Compare Pediatric Dermatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Arkansas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pediatric Dermatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arkansas
Frequently Asked Questions
What is Lindsay Lipke, M.D.'s specialty? ▼
How much does Lindsay Lipke, M.D. prescribe under Medicare Part D? ▼
What is Lindsay Lipke, M.D.'s Medicare quality score? ▼
Where is Lindsay Lipke, M.D. located? ▼
What is Lindsay Lipke, M.D.'s NPI number? ▼
Does Lindsay Lipke, M.D. prescribe more brand-name or generic drugs? ▼
How many Pediatric Dermatology Physician providers are there in the US? ▼
What drugs does Lindsay Lipke, M.D. prescribe most often? ▼
Does Lindsay Lipke, M.D. accept Medicare? ▼
How can I verify Lindsay Lipke, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology